Clarithromycin 250 mg b. i. d. for 5 or 10 days in the treatment of adult patients with purulent bronchitis
- 1 July 1993
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 21 (4) , 265-271
- https://doi.org/10.1007/bf01728910
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out‐patients with acute bacterial exacerbation of chronic bronchitisJournal of Internal Medicine, 1992
- Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological, and clinical overviewDiagnostic Microbiology and Infectious Disease, 1992
- Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Clarithromycin in the treatment of community-acquired lower respiratory tract infectionsJournal of Hospital Infection, 1991
- More macrolides.BMJ, 1991
- Efficacy and Tolerability of Clarithromycin in the Short-Course Treatment of Acute Respiratory Tract InfectionsClinical Drug Investigation, 1991
- Comparative study of clarithromycin and ampicillin in the treatment of patients with acute bacterial exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1991
- The comparative efficacy and safety of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitisJournal of Antimicrobial Chemotherapy, 1991
- A comparative study of clarithromycin and penicillin VK in the treatment of outpatients with streptococcal pharyngitisJournal of Antimicrobial Chemotherapy, 1991
- A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1991